Department of Cardiology Renmin Hospital of Wuhan University Wuhan 430060 Hubei Province ChinaCardiovascular Research Institute Wuhan University Wuhan 430060 Hubei Province ChinaHubei Key Laboratory of Cardiology Wuhan 430060 Hubei Province China;
Department of Cardiology Renmin Hospital of Wuhan University Wuhan 430060 Hubei Province ChinaCardiovascular Research Institute Wuhan University Wuhan 430060 Hubei Province ChinaHubei Key Laboratory of Cardiology Wuhan 430060 Hubei Province China;
Department of Cardiology Renmin Hospital of Wuhan University Wuhan 430060 Hubei Province ChinaCardiovascular Research Institute Wuhan University Wuhan 430060 Hubei Province ChinaHubei Key Laboratory of Cardiology Wuhan 430060 Hubei Province China;
School of Biotechnology and Biomolecular Sciences The University of New South Wales Sydney 2052 Australia;
Department of Cardiology Renmin Hospital of Wuhan University Wuhan 430060 Hubei Province ChinaCardiovascular Research Institute Wuhan University Wuhan 430060 Hubei Province ChinaHubei Key Laboratory of Cardiology Wuhan 430060 Hubei Province China;
COVID-19; Coagulation; Prothrombin time; Fibrin degradation products; Prognosis; Infectious disease;